European stocks inch up as Bayer, AB Foods support By Reuters

© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, November 8, 2021. REUTERS/Staff

(Reuters) – European shares steadied near record highs on Tuesday, as strong corporate earnings supported sentiment, while investors awaited fresh U.S. inflation data for clues on the interest rate outlook.

The pan-European inched up 0.1%, as of 0832 GMT, holding just below a record peak hit last week.

German agriculture and pharmaceutical firm Bayer (OTC:) climbed 2.6% after reporting a rise in quarterly adjusted earnings that beat analysts’ forecasts.

Upbeat earnings outlook from Primark-owner AB Foods (LON:) supported British stocks. ()

Insurers were among the biggest decliners, with German group Munich Re falling 3.1% after saying it expected more COVID-related losses in its reinsurance business than previously expected.

Wall Street indexes cheered the passage of the U.S. infrastructure bill on Monday, though worries that a high consumer prices reading on Wednesday could revive talks of interest rate hikes kept overall gains in check. [MKTS/GLOB]

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*